Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,163 | 2,416 | -23,564 | -23,297 | -16,495 |
| Depreciation Amortization | 378 | 190 | 665 | 483 | 305 |
| Accounts receivable | 815 | -251 | 55,149 | 56,101 | 892 |
| Other Working Capital | -21,605 | -13,544 | 14,969 | 30,295 | -16,906 |
| Other Operating Activity | -371 | 213 | -59,332 | -58,195 | -923 |
| Operating Cash Flow | $-16,620 | $-10,976 | $-12,113 | $5,387 | $-33,127 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,889 | 10,924 | 2,998 | -14,422 | 23,770 |
| PPE Investments | -89 | -38 | -287 | -164 | -164 |
| Net Acquisitions | N/A | N/A | 9,736 | 9,797 | 9,853 |
| Investing Cash Flow | $16,800 | $10,886 | $12,447 | $-4,789 | $33,459 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3 | -2 | -7 | -5 | -4 |
| Common Stock Issued | 1 | 1 | N/A | 575 | 430 |
| Other Financing Activity | 0 | 0 | 39 | -536 | -536 |
| Financing Cash Flow | $-2 | $-1 | $32 | $34 | $-110 |
| Beginning Cash Position | 1,306 | 1,306 | 940 | 940 | 940 |
| End Cash Position | 1,484 | 1,215 | 1,306 | 1,572 | 1,162 |
| Net Cash Flow | $178 | $-91 | $366 | $632 | $222 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,620 | -10,976 | -12,113 | 5,387 | -33,127 |
| Capital Expenditure | -89 | -38 | -304 | -181 | -181 |
| Free Cash Flow | -16,709 | -11,014 | -12,417 | 5,206 | -33,308 |